InvestSMART

MedAdvisor Limited (ASX: MDR) - Announcements

Current share price for MDR : $0.022 0.002 (10%)+

ASX company news and announcements for MedAdvisor Limited (MDR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All MedAdvisor Limited (MDR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than MedAdvisor Limited (MDR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for MedAdvisor Limited (MDR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- MedAdvisor to launch in Asia with Zuellig Pharma 3 Dec 2018 9:28AM $0.033 $0.022 fallen by 33.33%
- PEP and International Update 26 Nov 2018 12:32PM $0.031 $0.022 fallen by 29.03%
- Appendix 3Y Director's Interest Notice 12 Nov 2018 11:29AM $0.037 $0.022 fallen by 40.54%
- Appendix 3B Issue subsequent to Exercise of Options 12 Nov 2018 11:27AM $0.037 $0.022 fallen by 40.54%
- Performance Shares, Options and Release of Securities 12 Nov 2018 11:25AM $0.037 $0.022 fallen by 40.54%
- MedAdvisor Quarterly Report & Appendix 4C 26 Oct 2018 10:33AM $0.039 $0.022 fallen by 43.59%
- 2018 AGM Investor Presentation 23 Oct 2018 10:06AM $0.040 $0.022 fallen by 45%
- 2018 AGM Results & Chairman's Address 23 Oct 2018 10:04AM $0.040 $0.022 fallen by 45%
- Release from Escrow of Healthnotes Consideration Shares 17 Oct 2018 3:21PM $0.038 $0.022 fallen by 42.11%
- MedAdvisor Makes Strategic Appointments for US Expansion 10 Oct 2018 11:13AM $0.037 $0.022 fallen by 40.54%
- Notice of Annual General Meeting - 2018 4 Oct 2018 1:01PM $0.040 $0.022 fallen by 45%
- Appendix 3B Issue of Employee Incentive Options 1 Oct 2018 1:50PM $0.040 $0.022 fallen by 45%
- FY18 Results Investor Presentation 19 Sep 2018 10:26AM $0.040 $0.022 fallen by 45%
- MedAdvisor Expands Revenue Streams in Clinical Trials 10 Sep 2018 11:09AM $0.039 $0.022 fallen by 43.59%
- MedAdvisor FY18 Annual Report & Appendix 4E 31 Aug 2018 12:54PM $0.042 $0.022 fallen by 47.62%
- MedAdvisor Corporate Governance Statement 2018 31 Aug 2018 12:03PM $0.042 $0.022 fallen by 47.62%
- MedAdvisor Appendix 4G 30 June 18 31 Aug 2018 12:02PM $0.042 $0.022 fallen by 47.62%
- Ceasing to be a substantial holder from MUFG 31 Aug 2018 11:04AM $0.042 $0.022 fallen by 47.62%
- Ceasing to be a substantial holder from MS 30 Aug 2018 6:06PM $0.042 $0.022 fallen by 47.62%
- MedAdvisor and HPS Announce Integrated Medication Solution 30 Aug 2018 12:34PM $0.042 $0.022 fallen by 47.62%
- Appendix 3B Issue and Exercise of Employee Options 24 Aug 2018 11:39AM $0.044 $0.022 fallen by 50%
- Vesting of CEO Performance Rights 24 Aug 2018 11:22AM $0.044 $0.022 fallen by 50%
- Becoming a substantial holder from MUFG 24 Aug 2018 11:07AM $0.044 $0.022 fallen by 50%
- Becoming a substantial holder from MS 23 Aug 2018 4:41PM $0.044 $0.022 fallen by 50%
- MedAdvisor Quarterly Report & Appendix 4C 25 Jul 2018 1:12PM $0.047 $0.022 fallen by 53.19%

601 - 625 of 761 results

Page 25 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.